Trials / Completed
CompletedNCT03232320
Meditoxin® Treatment in Patients With Cervical Dystonia
A Prospective, Randomized, Multi-center, Phase III, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Cervical Dystonia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To determine the efficacy and safety of Meditoxin in subjects with cervical dystonia compared with placebo (normal saline)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meditoxin | Meditoxin (Botulinum toxin type A) |
| DRUG | Placebo | Placebo (Normal saline) |
Timeline
- Start date
- 2017-07-06
- Primary completion
- 2018-10-31
- Completion
- 2018-11-05
- First posted
- 2017-07-27
- Last updated
- 2019-03-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03232320. Inclusion in this directory is not an endorsement.